Pieris Pharmaceuticals, Inc.
PIRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6 | -$25 | -$33 | -$46 |
| Dep. & Amort. | $0 | $2 | $3 | $2 |
| Deferred Tax | $0 | -$5 | $0 | $0 |
| Stock-Based Comp. | $1 | $3 | $4 | $5 |
| Change in WC | $0 | -$7 | -$33 | $31 |
| Other Non-Cash | -$6 | -$23 | -$0 | -$0 |
| Operating Cash Flow | -$11 | -$54 | -$60 | -$8 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | -$12 | $20 | $0 |
| Inv. Purchases | $0 | -$23 | -$48 | $0 |
| Inv. Sales/Matur. | $0 | $35 | $28 | $0 |
| Other Inv. Act. | $0 | $12 | -$20 | $0 |
| Investing Cash Flow | $0 | $12 | -$21 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $20 | $7 | $57 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $87 | $20 | $0 | $2 |
| Financing Cash Flow | $87 | $20 | $7 | $59 |
| Forex Effect | $0 | $1 | -$5 | -$3 |
| Net Chg. in Cash | $76 | -$21 | -$79 | $47 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7 | $39 | $118 | $70 |
| End Cash | $84 | $17 | $39 | $118 |
| Free Cash Flow | -$11 | -$54 | -$61 | -$9 |